{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:29:35Z","timestamp":1789619375893,"version":"build-2803163510"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03361-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:42:39Z","timestamp":1772581359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rational Design of Amiodarone Co-crystals: A Synergistic Strategy Combining Computational Prediction, Precipitation-Inhibiting Polymers, and Formulation Optimisation"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6419-1147","authenticated-orcid":false,"given":"Rahul","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2066-6559","authenticated-orcid":false,"given":"Arzoo","family":"Sekhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6091-4357","authenticated-orcid":false,"given":"Heena A.","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-6671","authenticated-orcid":false,"given":"Nimeet","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1057-2566","authenticated-orcid":false,"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"3361_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020484","volume":"15","author":"J Lou","year":"2023","unstructured":"Lou J, Duan H, Qin Q, Teng Z, Gan F, Zhou X, Zhou X. Advances in oral drug delivery systems: challenges and opportunities. Pharmaceutics. 2023;15: 484. https:\/\/doi.org\/10.3390\/pharmaceutics15020484.","journal-title":"Pharmaceutics"},{"key":"3361_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","volume":"5","author":"S Kalepu","year":"2015","unstructured":"Kalepu S, Nekkanti V. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharm Sin B. 2015;5:442\u201353. https:\/\/doi.org\/10.1016\/j.apsb.2015.07.003.","journal-title":"Acta Pharm Sin B"},{"key":"3361_CR3","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-03020-4","volume":"26","author":"M Dhaval","year":"2025","unstructured":"Dhaval M, Dudhat K, Gadoya A, shah S, Pethani T, Jambukiya N, Patel A, Kalsariya C, Ansari J, Borkhataria C. Pharmaceutical salts: comprehensive insights fromfundamental chemistry to FDA approvals (2019\u20132023). AAPS PharmSciTech. 2025;26: 36. https:\/\/doi.org\/10.1208\/s12249-024-03020-4.","journal-title":"AAPS PharmSciTech"},{"key":"3361_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092055","volume":"10","author":"DV Bhalani","year":"2022","unstructured":"Bhalani DV, Nutan B, Kumar A, Singh Chandel AK. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines. 2022;10: 2055. https:\/\/doi.org\/10.3390\/biomedicines10092055.","journal-title":"Biomedicines"},{"key":"3361_CR5","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1021\/acs.cgd.5c00625","volume":"25","author":"BK Saha","year":"2025","unstructured":"Saha BK, Boro VR. Pharmaceutical cocrystals: a perspective. Cryst Growth Des. 2025;25:7353\u20139. https:\/\/doi.org\/10.1021\/acs.cgd.5c00625.","journal-title":"Cryst Growth Des"},{"key":"3361_CR6","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1021\/acs.chemrev.1c00987","volume":"122","author":"G Bolla","year":"2022","unstructured":"Bolla G, Sarma B, Nangia AK. Crystal engineering of pharmaceutical cocrystals in the discovery and development of improved drugs. Chem Rev. 2022;122:11514\u2013603. https:\/\/doi.org\/10.1021\/acs.chemrev.1c00987.","journal-title":"Chem Rev"},{"key":"3361_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/pharmaceutics10010018","volume":"10","author":"A Karagianni","year":"2018","unstructured":"Karagianni A, Malamatari M, Kachrimanis K. Pharmaceutical cocrystals: new solid phase modification approaches for the formulation of APIs. Pharmaceutics. 2018;10:18. https:\/\/doi.org\/10.3390\/pharmaceutics10010018.","journal-title":"Pharmaceutics"},{"key":"3361_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/17425247.2021.1844181","volume":"18","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Dong L, Guo J, Li L, Tian B, Zhao Q, Yang J. Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques. Expert Opin Drug Deliv. 2021;18:249\u201364. https:\/\/doi.org\/10.1080\/17425247.2021.1844181.","journal-title":"Expert Opin Drug Deliv"},{"key":"3361_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202502315","author":"N Desai","year":"2025","unstructured":"Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK. Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape. Small. 2025. https:\/\/doi.org\/10.1002\/smll.202502315.","journal-title":"Small"},{"key":"3361_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cssc.202301220","author":"A Bodach","year":"2024","unstructured":"Bodach A, Portet A, Winkelmann F, Herrmann B, Gallou F, Ponnusamy E, Virieux D, Colacino E, Felderhoff M. Scalability of pharmaceutical co\u2010crystal formation by mechanochemistry in batch. Chemsuschem. 2024. https:\/\/doi.org\/10.1002\/cssc.202301220.","journal-title":"Chemsuschem"},{"key":"3361_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1254\/fpj.145.36","volume":"145","author":"T Takasu","year":"2015","unstructured":"Takasu T, Takakura S, Kaku S. Pharmacological and clinical profile of ipragliflozin (Suglat\u00ae): a new therapeutic agent for type 2 diabetes. Folia Pharmacol Jpn. 2015;145:36\u201342. https:\/\/doi.org\/10.1254\/fpj.145.36.","journal-title":"Folia Pharmacol Jpn"},{"key":"3361_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.794","author":"AL Eadie","year":"2021","unstructured":"Eadie AL, Brunt KR, Herder M. Exploring the Food and Drug Administration\u2019s review and approval of Entresto (sacubitril\/valsartan). Pharmacol Res Perspect. 2021. https:\/\/doi.org\/10.1002\/prp2.794.","journal-title":"Pharmacol Res Perspect"},{"key":"3361_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120649","volume":"602","author":"DL Yarlagadda","year":"2021","unstructured":"Yarlagadda DL, Sai Krishna Anand V, Nair AR, Navya Sree KS, Dengale SJ, Bhat K. Considerations for the selection of co-formers in the preparation of co-amorphous formulations. Int J Pharm. 2021;602: 120649. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120649.","journal-title":"Int J Pharm"},{"key":"3361_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijpharm.2019.01.007","volume":"558","author":"A Salem","year":"2019","unstructured":"Salem A, Nagy S, P\u00e1l S, Sz\u00e9chenyi A. Reliability of the Hansen solubility parameters as co-crystal formation prediction tool. Int J Pharm. 2019;558:319\u201327. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.007.","journal-title":"Int J Pharm"},{"key":"3361_CR15","doi-asserted-by":"publisher","unstructured":"Klamt A. The COSMO and COSMO\u2010RS solvation models, WIREs Computat Mol Sci. 2018;8. https:\/\/doi.org\/10.1002\/wcms.1338.","DOI":"10.1002\/wcms.1338"},{"key":"3361_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092174","volume":"15","author":"Y Deng","year":"2023","unstructured":"Deng Y, Liu S, Jiang Y, Martins ICB, Rades T. Recent advances in co-former screening and formation prediction of multicomponent solid forms of low molecular weight drugs. Pharmaceutics. 2023;15: 2174. https:\/\/doi.org\/10.3390\/pharmaceutics15092174.","journal-title":"Pharmaceutics"},{"key":"3361_CR17","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1021\/cg5005243","volume":"14","author":"MV Vener","year":"2014","unstructured":"Vener MV, Levina EO, Koloskov OA, Rykounov AA, Voronin AP, Tsirelson VG. Evaluation of the lattice energy of the two-component molecular crystals using solid-state density functional theory. Cryst Growth Des. 2014;14:4997\u20135003. https:\/\/doi.org\/10.1021\/cg5005243.","journal-title":"Cryst Growth Des"},{"key":"3361_CR18","doi-asserted-by":"publisher","unstructured":"Dorian. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. Vasc Health Risk Manag. 2010;465. https:\/\/doi.org\/10.2147\/VHRM.S6611.","DOI":"10.2147\/VHRM.S6611"},{"key":"3361_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.fluid.2017.07.015","volume":"450","author":"G Sodeifian","year":"2017","unstructured":"Sodeifian G, Sajadian SA, Razmimanesh F. Solubility of an antiarrhythmic drug (amiodarone hydrochloride) in supercritical carbon dioxide: experimental and modeling. Fluid Phase Equilib. 2017;450:149\u201359. https:\/\/doi.org\/10.1016\/j.fluid.2017.07.015.","journal-title":"Fluid Phase Equilib"},{"key":"3361_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2022.119679","volume":"362","author":"H Share Mohammadi","year":"2022","unstructured":"Share Mohammadi H, Haghighi Asl A, Khajenoori M. Determination of amiodarone hydrochloride solubility in pure and ethanol-modified subcritical water: experimental data and modeling. J Mol Liq. 2022;362: 119679. https:\/\/doi.org\/10.1016\/j.molliq.2022.119679.","journal-title":"J Mol Liq"},{"key":"3361_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.11909\/j.issn.1671-5411.2019.07.004","volume":"16","author":"RM Colunga Biancatelli","year":"2019","unstructured":"Colunga Biancatelli RM, Congedo V, Calvosa L, Ciacciarelli M, Polidoro A, Iuliano L. Adverse reactions of amiodarone. J Geriatr Cardiol. 2019;16:552\u201366. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2019.07.004.","journal-title":"J Geriatr Cardiol"},{"key":"3361_CR22","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1590\/S1984-82502015000400021","volume":"51","author":"AM Rubim","year":"2015","unstructured":"Rubim AM, Rubenick JB, Gregolin E, Laporta LV, Leitenberg R, Rolim CMB. Amiodarone hydrochloride: enhancement of solubility and dissolution rate by solid dispersion technique. Braz J Pharm Sci. 2015;51:957\u201366. https:\/\/doi.org\/10.1590\/S1984-82502015000400021.","journal-title":"Braz J Pharm Sci"},{"key":"3361_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2024.118703","volume":"216","author":"N Jirofti","year":"2024","unstructured":"Jirofti N, Sarhaddi F, Poorsargol M, Jahani A, Rahiman N, Rahmani E, Rahdar A, Kalalinia F, Behzadmehr R, D\u00edez-Pascual AM. Lignin and Pluronic-based nanomicelles as promising amiodarone nanocarriers: synthesis, physical characterization, biological, and in silico evaluations. Ind Crops Prod. 2024;216: 118703. https:\/\/doi.org\/10.1016\/j.indcrop.2024.118703.","journal-title":"Ind Crops Prod"},{"key":"3361_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041161","volume":"15","author":"M Singh","year":"2023","unstructured":"Singh M, Barua H, Jyothi VGSS, Dhondale MR, Nambiar AG, Agrawal AK, Kumar P, Shastri NR, Kumar D. Cocrystals by design: a rational coformer selection approach for tackling the API problems. Pharmaceutics. 2023;15: 1161. https:\/\/doi.org\/10.3390\/pharmaceutics15041161.","journal-title":"Pharmaceutics"},{"key":"3361_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105422","volume":"152","author":"TC Machado","year":"2020","unstructured":"Machado TC, Kuminek G, Cardoso SG, Rodr\u00edguez-Hornedo N. The role of pH and dose\/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation. Eur J Pharm Sci. 2020;152: 105422. https:\/\/doi.org\/10.1016\/j.ejps.2020.105422.","journal-title":"Eur J Pharm Sci"},{"key":"3361_CR26","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.jddst.2020.101566","volume":"56","author":"M Omori","year":"2020","unstructured":"Omori M, Uekusa T, Oki J, Inoue D, Sugano K. Solution-mediated phase transformation at particle surface during cocrystal dissolution. J Drug Deliv Sci Technol. 2020;56:101566. https:\/\/doi.org\/10.1016\/j.jddst.2020.101566.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3361_CR27","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/jps.23588","volume":"102","author":"S Ozaki","year":"2013","unstructured":"Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs. J Pharm Sci. 2013;102:2273\u201381. https:\/\/doi.org\/10.1002\/jps.23588.","journal-title":"J Pharm Sci"},{"key":"3361_CR28","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1021\/acs.molpharmaceut.8b00482","volume":"15","author":"R Gurjar","year":"2018","unstructured":"Gurjar R, Chan CYS, Curley P, Sharp J, Chiong J, Rannard S, Siccardi M, Owen A. Inhibitory effects of commonly used excipients on P-glycoprotein in vitro. Mol Pharm. 2018;15:4835\u201342. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00482.","journal-title":"Mol Pharm"},{"key":"3361_CR29","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1039\/D3CE01252B","volume":"26","author":"F Molajafari","year":"2024","unstructured":"Molajafari F, Li T, Abbasichaleshtori M, Hajian Z. D. M, Cozzolino AF, Fandrick DR, Howe JD. Computational screening for prediction of co-crystals: method comparison and experimental validation. CrystEngComm. 2024;26:1620\u201336. https:\/\/doi.org\/10.1039\/D3CE01252B.","journal-title":"CrystEngComm"},{"key":"3361_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijpharm.2014.02.048","volume":"466","author":"AOL \u00c9vora","year":"2014","unstructured":"\u00c9vora AOL, Castro RAE, Maria TMR, Silva MR, ter Horst JH, Canotilho J, Eus\u00e9bio MES. A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate. Int J Pharm. 2014;466:68\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.02.048.","journal-title":"Int J Pharm"},{"key":"3361_CR31","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03048-0","volume":"26","author":"I Ehsan","year":"2025","unstructured":"Ehsan I, Shahid M, Natesan S, Faruk A, Sood AK, Khan T. Hansen solubility parameters, computational, and thermodynamic models for tofacitinib citrate solubility in neat mono solvents, and GastroPlus based predicted in vivo performance of subcutaneous solution in humans. AAPS PharmSciTech. 2025;26: 64. https:\/\/doi.org\/10.1208\/s12249-025-03048-0.","journal-title":"AAPS PharmSciTech"},{"key":"3361_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijpharm.2011.01.030","volume":"407","author":"MA Mohammad","year":"2011","unstructured":"Mohammad MA, Alhalaweh A, Velaga SP. Hansen solubility parameter as a tool to predict cocrystal formation. Int J Pharm. 2011;407:63\u201371. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.01.030.","journal-title":"Int J Pharm"},{"key":"3361_CR33","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1021\/acs.cgd.3c00683","volume":"23","author":"C Li","year":"2023","unstructured":"Li C, Zhang C, Yan Y, Liang W, Xu J, Chen W. Multicomponent crystals of clozapine with improved solubility: a combined theoretical and experimental strategy on coformer screening and structure-property. Cryst Growth Des. 2023;23:7295\u2013315. https:\/\/doi.org\/10.1021\/acs.cgd.3c00683.","journal-title":"Cryst Growth Des"},{"key":"3361_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/adsc.202001245","volume":"363","author":"P Ying","year":"2021","unstructured":"Ying P, Yu J, Su W. Liquid-assisted grinding mechanochemistry in the synthesis of pharmaceuticals. Adv Synth Catal. 2021;363:1246\u201371. https:\/\/doi.org\/10.1002\/adsc.202001245.","journal-title":"Adv Synth Catal"},{"key":"3361_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102003","volume":"14","author":"LM Mart\u00ednez","year":"2022","unstructured":"Mart\u00ednez LM, Cruz-Angeles J, V\u00e1zquez-D\u00e1vila M, Mart\u00ednez E, Cabada P, Navarrete-Bernal C, Cortez F. Mechanical activation by ball milling as a strategy to prepare highly soluble pharmaceutical formulations in the form of co-amorphous, co-crystals, or polymorphs. Pharmaceutics. 2022;14: 2003. https:\/\/doi.org\/10.3390\/pharmaceutics14102003.","journal-title":"Pharmaceutics"},{"key":"3361_CR36","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1080\/03639045.2022.2042553","volume":"47","author":"KR Chaudhari","year":"2021","unstructured":"Chaudhari KR, Savjani JK, Savjani KT, Shah H. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method. Drug Dev Ind Pharm. 2021;47:1633\u201342. https:\/\/doi.org\/10.1080\/03639045.2022.2042553.","journal-title":"Drug Dev Ind Pharm"},{"key":"3361_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4236\/ijoc.2023.132006","volume":"13","author":"S Suda","year":"2023","unstructured":"Suda S, Tateno A, Nakane D, Akitsu T. Hirshfeld surface analysis for investigation of intermolecular interaction of molecular crystals. Int J Org Chem (Irvine). 2023;13:57\u201385. https:\/\/doi.org\/10.4236\/ijoc.2023.132006.","journal-title":"Int J Org Chem (Irvine)"},{"key":"3361_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131721","volume":"1250","author":"M Suresh","year":"2022","unstructured":"Suresh M, Srinivasan K. Crystal structure and Hirshfeld surface analysis of dl-methionine polymorphs (\u03b1 and \u03b2). J Mol Struct. 2022;1250: 131721. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131721.","journal-title":"J Mol Struct"},{"key":"3361_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-024-06128-3","volume":"30","author":"T Sundareswaran","year":"2024","unstructured":"Sundareswaran T, Jagan R, Karthikeyan N, Boaz BM. Rational analysis of hydrogen bonding interaction in phenazine, 2-hydroxynaphthalene (1:1) cocrystal: from molecular modeling to photophysical properties. J Mol Model. 2024;30: 351. https:\/\/doi.org\/10.1007\/s00894-024-06128-3.","journal-title":"J Mol Model"},{"key":"3361_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1515\/zkri-2021-2061","volume":"237","author":"MM Rosli","year":"2022","unstructured":"Rosli MM, Khalib NC, Thanigaimani K, Arshad S, Razak IA. Structural, Hirshfeld surface and HOMO-LUMO gap analysis of five co-crystals of 2-amino-5-chloropyridine or 2-amino-bromopyridine with isomeric methylbenzoic acids. Z Kristallogr Crystalline Mater. 2022;237:249\u201358. https:\/\/doi.org\/10.1515\/zkri-2021-2061.","journal-title":"Z Kristallogr Crystalline Mater"},{"key":"3361_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.118885","volume":"245","author":"J Fang","year":"2021","unstructured":"Fang J, Zhang Z, Bo Y, Xue J, Wang Y, Liu J, Qin J, Hong Z, Du Y. Vibrational spectral and structural characterization of multicomponent ternary co-crystal formation within acetazolamide, nicotinamide and 2-pyridone. Spectrochim Acta A Mol Biomol Spectrosc. 2021;245: 118885. https:\/\/doi.org\/10.1016\/j.saa.2020.118885.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"3361_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cplu.202300166","author":"U Macio\u0142ek","year":"2023","unstructured":"Macio\u0142ek U, Mendyk E, Ku\u015bmierz M, Kozio\u0142 AE. Binary co\u2010crystals of Quercetin: synthesis, structure, and spectroscopic characterization. ChemPlusChem. 2023. https:\/\/doi.org\/10.1002\/cplu.202300166.","journal-title":"ChemPlusChem"},{"key":"3361_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121394","volume":"613","author":"L Wang","year":"2022","unstructured":"Wang L, Yan Y, Zhang X, Zhou X. Novel pharmaceutical cocrystal of lenalidomide with nicotinamide: structural design, evaluation, and thermal phase transition study. Int J Pharm. 2022;613: 121394. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121394.","journal-title":"Int J Pharm"},{"key":"3361_CR44","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-021-02182-9","volume":"23","author":"M Jagia","year":"2021","unstructured":"Jagia M, Kale DP, Bansal AK, Patel S. Novel co-crystals and eutectics of febuxostat: characterization, mechanism of formation, and improved dissolution. AAPS PharmSciTech. 2021;23: 43. https:\/\/doi.org\/10.1208\/s12249-021-02182-9.","journal-title":"AAPS PharmSciTech"},{"key":"3361_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cryst10010042","volume":"10","author":"O Al Rahal","year":"2020","unstructured":"Al Rahal O, Majumder M, Spillman MJ, van de Streek J, Shankland K. Co-crystal structures of Furosemide:urea and Carbamazepine:Indomethacin determined from powder X-ray diffraction data. Crystals. 2020;10: 42. https:\/\/doi.org\/10.3390\/cryst10010042.","journal-title":"Crystals"},{"key":"3361_CR46","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.xphs.2017.01.033","volume":"106","author":"SK Nechipadappu","year":"2017","unstructured":"Nechipadappu SK, Tekuri V, Trivedi DR. Pharmaceutical co-crystal of flufenamic acid: synthesis and characterization of two novel drug-drug co-crystal. J Pharm Sci. 2017;106:1384\u201390. https:\/\/doi.org\/10.1016\/j.xphs.2017.01.033.","journal-title":"J Pharm Sci"},{"key":"3361_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04864","volume":"6","author":"I Nugrahani","year":"2020","unstructured":"Nugrahani I, Auli WN. Diclofenac-proline nano-co-crystal development, characterization, in vitro dissolution and diffusion study. Heliyon. 2020;6: e04864. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04864.","journal-title":"Heliyon"},{"key":"3361_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijpharm.2013.05.048","volume":"453","author":"I Tomaszewska","year":"2013","unstructured":"Tomaszewska I, Karki S, Shur J, Price R, Fotaki N. Pharmaceutical characterisation and evaluation of cocrystals: importance of in vitro dissolution conditions and type of coformer. Int J Pharm. 2013;453:380\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.05.048.","journal-title":"Int J Pharm"},{"key":"3361_CR49","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02467-7","volume":"24","author":"D Yadav","year":"2022","unstructured":"Yadav D, Savjani J, Savjani K, Kumar A, Patel S. Pharmaceutical co-crystal of antiviral agent efavirenz with nicotinamide for the enhancement of solubility, physicochemical stability, and oral bioavailability. AAPS PharmSciTech. 2022;24: 7. https:\/\/doi.org\/10.1208\/s12249-022-02467-7.","journal-title":"AAPS PharmSciTech"},{"key":"3361_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.powtec.2012.02.020","volume":"222","author":"SP Mulye","year":"2012","unstructured":"Mulye SP, Jamadar SA, Karekar PS, Pore YV, Dhawale SC. Improvement in physicochemical properties of ezetimibe using a crystal engineering technique. Powder Technol. 2012;222:131\u20138. https:\/\/doi.org\/10.1016\/j.powtec.2012.02.020.","journal-title":"Powder Technol"},{"key":"3361_CR51","doi-asserted-by":"publisher","first-page":"135309","DOI":"10.1016\/j.molstruc.2023.135309","volume":"1284","author":"R Sharma","year":"2023","unstructured":"Sharma R, Singh M, Srijana PJ, Narayana B, Sarojini BK, Likhitha U, Murugavel S, Raj JM, Kant R. Synthesis, characterization, quantum chemical calculation, Hirshfeld surface analysis and antibacterial activity of a co-crystal of 4-Aminopyridine: p-Hydroxybenzoic acid with a water molecule. J Mol Struct. 2023;1284:135309. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135309.","journal-title":"J Mol Struct"},{"key":"3361_CR52","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00706-015-1413-z","volume":"146","author":"\u00d6 Dereli","year":"2015","unstructured":"Dereli \u00d6, Bah\u00e7eli S, Abbas A, Naseer MM. Quantum chemical investigations of a co-crystal of 1,3,5-tris(4-hydroxyphenyl)benzene and 2,4,6-trimethoxy-1,3,5-triazine. Monatshefte F\u00fcr Chemie Chem Monthly. 2015;146:1473\u201384. https:\/\/doi.org\/10.1007\/s00706-015-1413-z.","journal-title":"Monatshefte F\u00fcr Chemie Chem Monthly"},{"key":"3361_CR53","doi-asserted-by":"publisher","unstructured":"Scrivens G. ICH Q1E Evaluation for Stability Data. In: ICH Quality Guidelines, Wiley, 2017: pp. 89\u2013125. https:\/\/doi.org\/10.1002\/9781118971147.ch4.","DOI":"10.1002\/9781118971147.ch4"},{"key":"3361_CR54","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1039\/D1CE01327K","volume":"24","author":"L Liu","year":"2022","unstructured":"Liu L, Wang J-R, Mei X. Enhancing the stability of active pharmaceutical ingredients by the cocrystal strategy. CrystEngComm. 2022;24:2002\u201322. https:\/\/doi.org\/10.1039\/D1CE01327K.","journal-title":"CrystEngComm"},{"key":"3361_CR55","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1021\/acs.cgd.2c00787","volume":"22","author":"A Alvani","year":"2022","unstructured":"Alvani A, Shayanfar A. Solution stability of pharmaceutical cocrystals. Cryst Growth Des. 2022;22:6323\u201337. https:\/\/doi.org\/10.1021\/acs.cgd.2c00787.","journal-title":"Cryst Growth Des"},{"key":"3361_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12010023","volume":"12","author":"R Salas-Z\u00fa\u00f1iga","year":"2019","unstructured":"Salas-Z\u00fa\u00f1iga R, Rodr\u00edguez-Ruiz C, H\u00f6pfl H, Morales-Rojas H, S\u00e1nchez-Guadarrama O, Rodr\u00edguez-Cuamatzi P, Herrera-Ruiz D. Dissolution advantage of Nitazoxanide cocrystals in the presence of cellulosic polymers. Pharmaceutics. 2019;12: 23. https:\/\/doi.org\/10.3390\/pharmaceutics12010023.","journal-title":"Pharmaceutics"},{"key":"3361_CR57","doi-asserted-by":"publisher","first-page":"103029","DOI":"10.1016\/j.jddst.2021.103029","volume":"67","author":"M Shigemura","year":"2022","unstructured":"Shigemura M, Omori M, Sugano K. Polymeric precipitation inhibitor differently affects cocrystal surface and bulk solution phase transformations. J Drug Deliv Sci Technol. 2022;67:103029. https:\/\/doi.org\/10.1016\/j.jddst.2021.103029.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3361_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125743","volume":"680","author":"R Verma","year":"2025","unstructured":"Verma R, Anjum MM, Sharma D, Patel KK, Bhattacharya S, Singh S. Synthesis and evaluation of valsartan co-crystals for enhanced solubility and anti-hypertensive activity. Int J Pharm. 2025;680: 125743. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125743.","journal-title":"Int J Pharm"},{"key":"3361_CR59","doi-asserted-by":"publisher","unstructured":"Beg S, Rahman Z. Central composite designs and their applications in pharmaceutical product development. In: Design of experiments for pharmaceutical product development. Singapore: Springer Singapore; 2021: p. 63\u201376. https:\/\/doi.org\/10.1007\/978-981-33-4717-5_6.","DOI":"10.1007\/978-981-33-4717-5_6"},{"key":"3361_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/adv.21536","volume":"35","author":"U Asif","year":"2016","unstructured":"Asif U, Sherwani AK, Akhtar N, Shoaib MH, Hanif M, Qadir MI, Zaman M. Formulation development and optimization of Febuxostat tablets by direct compression method. Adv Polym Technol. 2016;35:129\u201335. https:\/\/doi.org\/10.1002\/adv.21536.","journal-title":"Adv Polym Technol"},{"key":"3361_CR61","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1080\/10837450.2016.1242625","volume":"23","author":"MF Arafa","year":"2018","unstructured":"Arafa MF, El-Gizawy SA, Osman MA, El Maghraby GM. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets. Pharm Dev Technol. 2018;23:454\u201363. https:\/\/doi.org\/10.1080\/10837450.2016.1242625.","journal-title":"Pharm Dev Technol"},{"key":"3361_CR62","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3109\/03639045.2015.1118495","volume":"42","author":"MF Arafa","year":"2016","unstructured":"Arafa MF, El-Gizawy SA, Osman MA, El Maghraby GM. Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets. Drug Dev Ind Pharm. 2016;42:1225\u201333. https:\/\/doi.org\/10.3109\/03639045.2015.1118495.","journal-title":"Drug Dev Ind Pharm"},{"key":"3361_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261051","volume":"16","author":"A Khan","year":"2021","unstructured":"Khan A. Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation. PLoS ONE. 2021;16: e0261051. https:\/\/doi.org\/10.1371\/journal.pone.0261051.","journal-title":"PLoS ONE"},{"key":"3361_CR64","doi-asserted-by":"publisher","first-page":"105167","DOI":"10.1016\/j.jddst.2023.105167","volume":"90","author":"MS Mohamed","year":"2023","unstructured":"Mohamed MS, El-Shenawy AA, hakim Ramadan AE, Mahmoud EA, Amin MA, Mohammed HA, Shaldam MA, Mahmoud RA. Metolazone co-crystals-loaded oral fast dissolving films: design, optimization, and in vivo evaluation. J Drug Deliv Sci Technol. 2023;90:105167. https:\/\/doi.org\/10.1016\/j.jddst.2023.105167.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3361_CR65","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/jphp.12376","volume":"67","author":"C Loschen","year":"2015","unstructured":"Loschen C, Klamt A. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering. J Pharm Pharmacol. 2015;67:803\u201311. https:\/\/doi.org\/10.1111\/jphp.12376.","journal-title":"J Pharm Pharmacol"},{"key":"3361_CR66","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1021\/acs.cgd.1c00415","volume":"21","author":"D Wu","year":"2021","unstructured":"Wu D, Zhang B, Yao Q, Hou B, Zhou L, Xie C, Gong J, Hao H, Chen W. Evaluation on cocrystal screening methods and synthesis of multicomponent crystals: a case study. Cryst Growth Des. 2021;21:4531\u201346. https:\/\/doi.org\/10.1021\/acs.cgd.1c00415.","journal-title":"Cryst Growth Des"},{"key":"3361_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2025.127841","volume":"433","author":"R Jha","year":"2025","unstructured":"Jha R, Sekhani A, Panchal N, Shah P. In silico cocrystal screening using COSMO-RS: a rapid and efficient approach for solubility prediction and crystal engineering. J Mol Liq. 2025;433: 127841. https:\/\/doi.org\/10.1016\/j.molliq.2025.127841.","journal-title":"J Mol Liq"},{"key":"3361_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2024.125319","volume":"408","author":"C Li","year":"2024","unstructured":"Li C, Li Z, Liu X, Xu J, Zhang C. Machine learning approach to predict Hansen solubility parameters of cocrystal coformers via integrating group contribution and COSMO-RS. J Mol Liq. 2024;408: 125319. https:\/\/doi.org\/10.1016\/j.molliq.2024.125319.","journal-title":"J Mol Liq"},{"key":"3361_CR69","doi-asserted-by":"publisher","unstructured":"Loschen C, Klamt A. New Developments in Prediction of Solid\u2010State Solubility and Cocrystallization Using COSMO\u2010RS Theory. Computat Pharm Solid State Chem. 2016;22:211-33. https:\/\/doi.org\/10.1002\/9781118700686.ch9.","DOI":"10.1002\/9781118700686.ch9"},{"key":"3361_CR70","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.fluid.2009.11.018","volume":"289","author":"B Schr\u00f6der","year":"2010","unstructured":"Schr\u00f6der B, Santos LMNBF, Marrucho IM, Coutinho JAP. Prediction of aqueous solubilities of solid carboxylic acids with COSMO-RS. Fluid Phase Equilib. 2010;289:140\u20137. https:\/\/doi.org\/10.1016\/j.fluid.2009.11.018.","journal-title":"Fluid Phase Equilib"},{"key":"3361_CR71","doi-asserted-by":"publisher","first-page":"13131","DOI":"10.5194\/acp-20-13131-2020","volume":"20","author":"N Hyttinen","year":"2020","unstructured":"Hyttinen N, Heshmatnezhad R, Elm J, Kurt\u00e9n T, Prisle NL. Technical note: estimating aqueous solubilities and activity coefficients of mono- and \u03b1 , \u03c9 -dicarboxylic acids using COSMO therm. Atmos Chem Phys. 2020;20:13131\u201343. https:\/\/doi.org\/10.5194\/acp-20-13131-2020.","journal-title":"Atmos Chem Phys"},{"key":"3361_CR72","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10973-016-5256-6","volume":"126","author":"A Lede\u0163i","year":"2016","unstructured":"Lede\u0163i A, Vlase G, Vlase T, Bercean V, Murariu MS, Lede\u0163i I, \u015euta L-M. Solid-state preformulation studies of amiodarone hydrochloride. J Therm Anal Calorim. 2016;126:181\u20137. https:\/\/doi.org\/10.1007\/s10973-016-5256-6.","journal-title":"J Therm Anal Calorim"},{"key":"3361_CR73","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/cg025545e","volume":"2","author":"L Feng","year":"2002","unstructured":"Feng L, Berglund KA. ATR-FTIR for determining optimal cooling curves for batch crystallization of succinic acid. Cryst Growth Des. 2002;2:449\u201352. https:\/\/doi.org\/10.1021\/cg025545e.","journal-title":"Cryst Growth Des"},{"key":"3361_CR74","doi-asserted-by":"publisher","first-page":"10418","DOI":"10.1021\/acs.macromol.4c00614","volume":"57","author":"D Carboni","year":"2024","unstructured":"Carboni D, Cadeddu M, Stagi L, Anedda R, Menduti L, De Cola L, Malfatti L, Innocenzi P. Structural insights into low-temperature copolymerization of thermodegradable amino acids mediated by pyroglutamic acid. Macromolecules. 2024;57:10418\u201331. https:\/\/doi.org\/10.1021\/acs.macromol.4c00614.","journal-title":"Macromolecules"},{"key":"3361_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24234245","volume":"24","author":"I Budziak","year":"2019","unstructured":"Budziak I, Arczewska M, Kami\u0144ski DM. Formation of prenylated chalcone xanthohumol cocrystals: single crystal X-ray diffraction, vibrational spectroscopic study coupled with multivariate analysis. Molecules. 2019;24: 4245. https:\/\/doi.org\/10.3390\/molecules24234245.","journal-title":"Molecules"},{"key":"3361_CR76","doi-asserted-by":"publisher","first-page":"102233","DOI":"10.1016\/j.jddst.2020.102233","volume":"61","author":"J Pantwalawalkar","year":"2021","unstructured":"Pantwalawalkar J, More H, Bhange D, Patil U, Jadhav N. Novel curcumin ascorbic acid cocrystal for improved solubility. J Drug Deliv Sci Technol. 2021;61:102233. https:\/\/doi.org\/10.1016\/j.jddst.2020.102233.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3361_CR77","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3109\/03639045.2010.534099","volume":"37","author":"MI Yoshida","year":"2011","unstructured":"Yoshida MI, Lima Gomes EC, Vianna Soares CD, Oliveira MA. Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions. Drug Dev Ind Pharm. 2011;37:638\u201347. https:\/\/doi.org\/10.3109\/03639045.2010.534099.","journal-title":"Drug Dev Ind Pharm"},{"key":"3361_CR78","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1021\/cg200492w","volume":"11","author":"NJ Babu","year":"2011","unstructured":"Babu NJ, Nangia A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 2011;11:2662\u201379. https:\/\/doi.org\/10.1021\/cg200492w.","journal-title":"Cryst Growth Des"},{"key":"3361_CR79","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1021\/cg300784v","volume":"12","author":"P Sanphui","year":"2012","unstructured":"Sanphui P, Kumar SS, Nangia A. Pharmaceutical cocrystals of Niclosamide. Cryst Growth Des. 2012;12:4588\u201399. https:\/\/doi.org\/10.1021\/cg300784v.","journal-title":"Cryst Growth Des"},{"key":"3361_CR80","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.supflu.2010.01.010","volume":"53","author":"L Padrela","year":"2010","unstructured":"Padrela L, Rodrigues MA, Velaga SP, Fernandes AC, Matos HA, de Azevedo EG. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process. J Supercrit Fluids. 2010;53:156\u201364. https:\/\/doi.org\/10.1016\/j.supflu.2010.01.010.","journal-title":"J Supercrit Fluids"},{"key":"3361_CR81","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.xphs.2017.10.033","volume":"107","author":"KL Cavanagh","year":"2018","unstructured":"Cavanagh KL, Maheshwari C, Rodr\u00edguez-Hornedo N. Understanding the differences between cocrystal and salt aqueous solubilities. J Pharm Sci. 2018;107:113\u201320. https:\/\/doi.org\/10.1016\/j.xphs.2017.10.033.","journal-title":"J Pharm Sci"},{"key":"3361_CR82","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.matpr.2022.02.543","volume":"57","author":"BHJ Gowda","year":"2022","unstructured":"Gowda BHJ, Ahmed MG, Shankar SJ, Paul K, Chandan RS, Sanjana A, Narayana S, Nasrine A, Noushida N, Thriveni M. Preparation and characterization of efavirenz cocrystals: an endeavor to improve the physicochemical parameters. Mater Today Proc. 2022;57:878\u201386. https:\/\/doi.org\/10.1016\/j.matpr.2022.02.543.","journal-title":"Mater Today Proc"},{"key":"3361_CR83","doi-asserted-by":"publisher","first-page":"101958","DOI":"10.1016\/j.jddst.2020.101958","volume":"60","author":"JB Ngilirabanga","year":"2020","unstructured":"Ngilirabanga JB, Rosa PP, Aucamp M, Kippie Y, Samsodien H. Dual-drug co-crystal synthesis for synergistic in vitro effect of three key first-line antiretroviral drugs. J Drug Deliv Sci Technol. 2020;60:101958. https:\/\/doi.org\/10.1016\/j.jddst.2020.101958.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3361_CR84","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1039\/D1CE01084K","volume":"23","author":"PMJ Szell","year":"2021","unstructured":"Szell PMJ, Lewandowski JR, Blade H, Hughes LP, Nilsson Lill SO, Brown SP. Taming the dynamics in a pharmaceutical by cocrystallization: investigating the impact of the coformer by solid-state NMR. CrystEngComm. 2021;23:6859\u201370. https:\/\/doi.org\/10.1039\/D1CE01084K.","journal-title":"CrystEngComm"},{"key":"3361_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030108","volume":"10","author":"I Sathisaran","year":"2018","unstructured":"Sathisaran I, Dalvi S. Engineering cocrystals of poorly water-soluble drugs to enhance dissolution in aqueous medium. Pharmaceutics. 2018;10: 108. https:\/\/doi.org\/10.3390\/pharmaceutics10030108.","journal-title":"Pharmaceutics"},{"key":"3361_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-4-S1-O14","volume":"4","author":"A Klamt","year":"2012","unstructured":"Klamt A. Solvent-screening and co-crystal screening for drug development with COSMO-RS. J Cheminform. 2012;4: O14. https:\/\/doi.org\/10.1186\/1758-2946-4-S1-O14.","journal-title":"J Cheminform"},{"key":"3361_CR87","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1021\/acs.cgd.3c00776","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, Jiang Z, Wang L, Cheng Y, Fan W, Bian L, Shi Y, Zheng L-Y, Cao Q-E. Hydrogen bond-modulating luminescent properties of organic cocrystal materials. Cryst Growth Des. 2024;24:132\u201342. https:\/\/doi.org\/10.1021\/acs.cgd.3c00776.","journal-title":"Cryst Growth Des"},{"key":"3361_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102493","volume":"15","author":"H Huang","year":"2023","unstructured":"Huang H, Zhang Y, Liu Y, Guo Y, Hu C. Influence of intermolecular interactions on crystallite size in crystalline solid dispersions. Pharmaceutics. 2023;15: 2493. https:\/\/doi.org\/10.3390\/pharmaceutics15102493.","journal-title":"Pharmaceutics"},{"key":"3361_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/cryst13040640","volume":"13","author":"VV Chernyshev","year":"2023","unstructured":"Chernyshev VV. Structural characterization of pharmaceutical cocrystals with the use of laboratory X-ray powder diffraction patterns. Crystals. 2023;13: 640. https:\/\/doi.org\/10.3390\/cryst13040640.","journal-title":"Crystals"},{"key":"3361_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010189","volume":"15","author":"MR Dhondale","year":"2023","unstructured":"Dhondale MR, Thakor P, Nambiar AG, Singh M, Agrawal AK, Shastri NR, Kumar D. Co-crystallization approach to enhance the stability of moisture-sensitive drugs. Pharmaceutics. 2023;15: 189. https:\/\/doi.org\/10.3390\/pharmaceutics15010189.","journal-title":"Pharmaceutics"},{"key":"3361_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103451","volume":"73","author":"IFB Biscaia","year":"2022","unstructured":"Biscaia IFB, da Luz JP, de O. Hykavei G, Bernardi LS, de Oliveira PR. Polymer selection to increase in vitro supersaturation generated by lamotrigine nicotinamide monohydrate cocrystal: an evaluation with predissolved and solid polymers. J Drug Deliv Sci Technol. 2022;73: 103451. https:\/\/doi.org\/10.1016\/j.jddst.2022.103451.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3361_CR92","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1021\/acs.molpharmaceut.0c00713","volume":"17","author":"KL Cavanagh","year":"2020","unstructured":"Cavanagh KL, Kuminek G, Rodr\u00edguez-Hornedo N. Cocrystal solubility advantage and dose\/solubility ratio diagrams: a mechanistic approach to selecting additives and controlling dissolution\u2013supersaturation\u2013precipitation behavior. Mol Pharm. 2020;17:4286\u2013301. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00713.","journal-title":"Mol Pharm"},{"key":"3361_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/DDC-43918","volume":"31","author":"C Liu","year":"2005","unstructured":"Liu C, Desai KGH, Liu C. Enhancement of dissolution rate of Valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev Ind Pharm. 2005;31:1\u201310. https:\/\/doi.org\/10.1081\/DDC-43918.","journal-title":"Drug Dev Ind Pharm"},{"key":"3361_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2021.100103","volume":"3","author":"J Lenz","year":"2021","unstructured":"Lenz J, Finke JH, Bunjes H, Kwade A, Juhnke M. Tablet formulation development focusing on the functional behaviour of water uptake and swelling. Int J Pharm X. 2021;3: 100103. https:\/\/doi.org\/10.1016\/j.ijpx.2021.100103.","journal-title":"Int J Pharm X"},{"key":"3361_CR95","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1080\/03639045.2018.1453519","volume":"44","author":"B Yang","year":"2018","unstructured":"Yang B, Wei C, Yang Y, Wang Q, Li S. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Drug Dev Ind Pharm. 2018;44:1417\u201325. https:\/\/doi.org\/10.1080\/03639045.2018.1453519.","journal-title":"Drug Dev Ind Pharm"},{"key":"3361_CR96","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1208\/s12249-010-9541-6","volume":"11","author":"SG Late","year":"2010","unstructured":"Late SG, Banga AK. Response surface methodology to optimize novel fast disintegrating tablets using \u03b2 cyclodextrin as diluent. AAPS PharmSciTech. 2010;11:1627\u201335. https:\/\/doi.org\/10.1208\/s12249-010-9541-6.","journal-title":"AAPS PharmSciTech"},{"key":"3361_CR97","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejps.2017.01.028","volume":"101","author":"J Yao","year":"2017","unstructured":"Yao J, Zhang Y, Hu Q, Zeng D, Hua F, Meng W, Wang W, Bao G-H. Optimization of paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties. Eur J Pharm Sci. 2017;101:189\u201399. https:\/\/doi.org\/10.1016\/j.ejps.2017.01.028.","journal-title":"Eur J Pharm Sci"},{"key":"3361_CR98","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1208\/s12249-016-0646-4","volume":"18","author":"D Wang","year":"2017","unstructured":"Wang D, Chen G, Ren L. Preparation and characterization of the sulfobutylether-\u03b2-cyclodextrin inclusion complex of Amiodarone hydrochloride with enhanced oral bioavailability in fasted state. AAPS PharmSciTech. 2017;18:1526\u201335. https:\/\/doi.org\/10.1208\/s12249-016-0646-4.","journal-title":"AAPS PharmSciTech"},{"key":"3361_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061300","volume":"14","author":"AM Awan","year":"2022","unstructured":"Awan AM, Farid A, Shah SU, Khan D, Ur Rehman F, Dar MJ, Iftikhar T, Ghazanfar S, Galanakis CM, Alamri AS, Asdaq SMB, Shah KU. Nanocrytals-mediated oral drug delivery: enhanced bioavailability of amiodarone. Pharmaceutics. 2022;14: 1300. https:\/\/doi.org\/10.3390\/pharmaceutics14061300.","journal-title":"Pharmaceutics"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03361-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03361-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03361-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:49:53Z","timestamp":1780390193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03361-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03361-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve the use of animals or human participants. All institutional and national regulations regarding research conduct were adhered to throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors have read and provided consent for the publication of the research manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Clinical trial number. Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"123"}}